These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33382405)

  • 21. The Optimal Cutoff Value to Predict HIV Infection Using the Architect HIV Ag/Ab Combo.
    Zhang X; Zhou X; He X; Liu X; Wang Z
    Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay.
    Lavoie S; Caswell D; Gill MJ; Kadkhoda K; Charlton CL; Levett PN; Hatchette T; Garceau R; Maregmen J; Mazzulli T; Needle R; Kadivar K; Kim J
    J Clin Virol; 2018 Jul; 104():23-28. PubMed ID: 29704735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.
    Piwowar-Manning E; Fogel JM; Richardson P; Wolf S; Clarke W; Marzinke MA; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Clin Virol; 2015 Jan; 62():75-9. PubMed ID: 25542477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort.
    Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; Gori A; Antinori A; Tambussi G; Bandera A;
    HIV Med; 2020 Sep; 21(8):523-535. PubMed ID: 32578947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.
    Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S
    J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Elecsys® HIV combi PT assay for screening and reliable early detection of HIV-1 infection in Asia.
    Tao CM; Cho Y; Ng KP; Han X; Oh EJ; Zainah S; Rozainanee MZ; Wang LL
    J Clin Virol; 2013 Sep; 58(1):221-6. PubMed ID: 23809476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology.
    de Souza MS; Pinyakorn S; Akapirat S; Pattanachaiwit S; Fletcher JL; Chomchey N; Kroon ED; Ubolyam S; Michael NL; Robb ML; Phanuphak P; Kim JH; Phanuphak N; Ananworanich J;
    Clin Infect Dis; 2016 Aug; 63(4):555-61. PubMed ID: 27317797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of the Bio-Rad Geenius HIV-1/2 Confirmatory Assay and the Bio-Rad Multispot HIV-1/2 Rapid Test as an alternative differentiation assay for CLSI M53 algorithm-I.
    Malloch L; Kadivar K; Putz J; Levett PN; Tang J; Hatchette TF; Kadkhoda K; Ng D; Ho J; Kim J
    J Clin Virol; 2013 Dec; 58 Suppl 1():e85-91. PubMed ID: 24342484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of suboptimal CD4
    Handoko R; Colby DJ; Kroon E; Sacdalan C; de Souza M; Pinyakorn S; Prueksakaew P; Munkong C; Ubolyam S; Akapirat S; Chiarella J; Krebs S; Sereti I; Valcour V; Paul R; Michael NL; Phanuphak N; Ananworanich J; Spudich S;
    J Int AIDS Soc; 2020 Sep; 23(9):e25585. PubMed ID: 32949118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fourth-generation rapid combined antigen and antibody diagnostic tests for the detection of acute HIV infection in a community centre for men who have sex with men, between 2016 and 2019.
    Saz J; Dalmau-Bueno A; Meulbroek M; Pujol F; Coll J; Herraiz-Tomey Á; Pérez F; Marazzi G; Taboada H; Culqui DR; Caylà JA;
    PLoS One; 2021; 16(7):e0255065. PubMed ID: 34314468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE II): protocol for a randomized evaluation.
    Rosen S; Maskew M; Brennan AT; Fox MP; Vezi L; Ehrenkranz PD; Venter WDF
    Trials; 2018 Oct; 19(1):548. PubMed ID: 30305142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.
    Ananworanich J; Eller LA; Pinyakorn S; Kroon E; Sriplenchan S; Fletcher JL; Suttichom D; Bryant C; Trichavaroj R; Dawson P; Michael N; Phanuphak N; Robb ML
    J Int AIDS Soc; 2017 Jun; 20(1):21652. PubMed ID: 28691436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and treatment of Fiebig stage I HIV-1 infection in young at-risk women in South Africa: a prospective cohort study.
    Dong KL; Moodley A; Kwon DS; Ghebremichael MS; Dong M; Ismail N; Ndhlovu ZM; Mabuka JM; Muema DM; Pretorius K; Lin N; Walker BD; Ndung'u T
    Lancet HIV; 2018 Jan; 5(1):e35-e44. PubMed ID: 28978417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
    PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Architect HIV Ag/Ab Combo Assay in a low-prevalence setting: The role of samples with a low S/CO ratio.
    Alonso R; Pérez-García F; Gijón P; Collazos A; Bouza E
    J Clin Virol; 2018 Jun; 103():43-47. PubMed ID: 29635210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
    Montesinos I; Eykmans J; Delforge ML
    J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
    Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
    J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection.
    Wratil PR; Rabenau HF; Eberle J; Stern M; Münchhoff M; Friedrichs I; Stürmer M; Berger A; Kuttner-May S; Münstermann D; Lucht A; Meixenberger K; Bannert N; Keppler OT
    Med Microbiol Immunol; 2020 Apr; 209(2):139-150. PubMed ID: 32036450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging of recent HIV-1 infection using Geenius rapid confirmatory assay compared to INNO-LIA, New Lav and Blot 2.2 assays.
    Tuaillon E; Sanosyan A; Pisoni A; Liscouët J; Makinson A; Perre PV
    J Clin Virol; 2017 Oct; 95():47-51. PubMed ID: 28843384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.